These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 657595

  • 1. Membranoproliferative glomerulonephritis (MPGN type I) and dense deposit disease (DDD) in children.
    Davis AE, Schneeberger EE, Grupe WE, McCluskey RT.
    Clin Nephrol; 1978 May; 9(5):184-93. PubMed ID: 657595
    [Abstract] [Full Text] [Related]

  • 2. Membranoproliferative glomerulonephritis with dense intramembranous alterations. A clinicopathologic study.
    Lamb V, Tisher CC, McCoy RC, Robinson RR.
    Lab Invest; 1977 Jun; 36(6):607-17. PubMed ID: 325295
    [Abstract] [Full Text] [Related]

  • 3. Biological significance of the C3 nephritic factor in membranoproliferative glomerulonephritis.
    Schena FP, Pertosa G, Stanziale P, Vox E, Pecoraro C, Andreucci VE.
    Clin Nephrol; 1982 Nov; 18(5):240-6. PubMed ID: 7151338
    [Abstract] [Full Text] [Related]

  • 4. [Familial membranoproliferative glomerulonephritis].
    Bogdanović RM, Dimitrjević JZ, Nikolić VN, Ognjanović MV, Rodić BD, Slavković BV.
    Srp Arh Celok Lek; 1999 Nov; 127(5-6):163-71. PubMed ID: 10500423
    [Abstract] [Full Text] [Related]

  • 5. Hereditary and acquired complement dysregulation in membranoproliferative glomerulonephritis.
    Licht C, Fremeaux-Bacchi V.
    Thromb Haemost; 2009 Feb; 101(2):271-8. PubMed ID: 19190809
    [Abstract] [Full Text] [Related]

  • 6. Type 3 membranoproliferative glomerulonephritis: clinicopathologic correlations and long-term follow-up in nine patients.
    Abreo K, Moorthy AV.
    Arch Pathol Lab Med; 1982 Aug; 106(8):413-7. PubMed ID: 6896632
    [Abstract] [Full Text] [Related]

  • 7. Characteristics of a benign subtype of dense deposit disease: comparison with the progressive form of this disease.
    Klein M, Poucell S, Arbus GS, McGraw M, Rance CP, Yoon SJ, Baumal R.
    Clin Nephrol; 1983 Oct; 20(4):163-71. PubMed ID: 6556977
    [Abstract] [Full Text] [Related]

  • 8. Clinico-pathologic spectrum of C3 glomerulopathy-an Indian experience.
    Viswanathan GK, Nada R, Kumar A, Ramachandran R, Rayat CS, Jha V, Sakhuja V, Joshi K.
    Diagn Pathol; 2015 Mar 17; 10():6. PubMed ID: 25889427
    [Abstract] [Full Text] [Related]

  • 9. Dense intramembranous deposit disease: a clinical comparison of histological subtypes.
    Kashtan CE, Burke B, Burch G, Gustav Fisker S, Kim Y.
    Clin Nephrol; 1990 Jan 17; 33(1):1-6. PubMed ID: 2302866
    [Abstract] [Full Text] [Related]

  • 10. Primary glomerulonephritis with isolated C3 deposits: a new entity which shares common genetic risk factors with haemolytic uraemic syndrome.
    Servais A, Frémeaux-Bacchi V, Lequintrec M, Salomon R, Blouin J, Knebelmann B, Grünfeld JP, Lesavre P, Noël LH, Fakhouri F.
    J Med Genet; 2007 Mar 17; 44(3):193-9. PubMed ID: 17018561
    [Abstract] [Full Text] [Related]

  • 11. Management of membranoproliferative glomerulonephritis type II with plasmapheresis.
    Kurtz KA, Schlueter AJ.
    J Clin Apher; 2002 Mar 17; 17(3):135-7. PubMed ID: 12378549
    [Abstract] [Full Text] [Related]

  • 12. Membranoproliferative glomerulonephritis type II (dense deposit disease): an update.
    Appel GB, Cook HT, Hageman G, Jennette JC, Kashgarian M, Kirschfink M, Lambris JD, Lanning L, Lutz HU, Meri S, Rose NR, Salant DJ, Sethi S, Smith RJ, Smoyer W, Tully HF, Tully SP, Walker P, Welsh M, Würzner R, Zipfel PF.
    J Am Soc Nephrol; 2005 May 17; 16(5):1392-403. PubMed ID: 15800116
    [Abstract] [Full Text] [Related]

  • 13. Heterogeneous histologic and clinical evolution in 3 cases of dense deposit disease with long-term follow-up.
    Figuères ML, Frémeaux-Bacchi V, Rabant M, Galmiche L, Marinozzi MC, Grünfeld JP, Noël LH, Servais A.
    Hum Pathol; 2014 Nov 17; 45(11):2326-33. PubMed ID: 25260719
    [Abstract] [Full Text] [Related]

  • 14. Mesangial proliferative glomerulonephritis with unusual intramembranous granular dense deposits.
    Mampaso F, Leyva-Cobián F, Martínez-Montero JC, Gonzalo A, Bellas C, Moneo I, Junquera E.
    Clin Nephrol; 1983 Feb 17; 19(2):92-8. PubMed ID: 6188567
    [Abstract] [Full Text] [Related]

  • 15. Membranoproliferative glomerulonephritis characterized by focal, segmental proliferative lesions.
    Strife CF, McAdams AJ, West CD.
    Clin Nephrol; 1982 Jul 17; 18(1):9-16. PubMed ID: 6749363
    [Abstract] [Full Text] [Related]

  • 16. [Membranoproliferative glomerulonephritis. Variability of a morphologically definable disease].
    Anders D, Bläker F, Gekle D, Kehrberg H.
    Klin Padiatr; 1982 Jul 17; 194(3):173-81. PubMed ID: 7132223
    [Abstract] [Full Text] [Related]

  • 17. [Long-term evolution of membranoproliferative glomerulonephritis in adults : spontaneous clinical remission in 13 cases with proven regression of glomerular lesions in 5 cases (author's transl)].
    Droz D, Noel LH, Barbanel C, Grünfeld JP.
    Nephrologie; 1982 Jul 17; 3(1):6-11. PubMed ID: 7088263
    [Abstract] [Full Text] [Related]

  • 18. Differences between membranoproliferative glomerulonephritis types I and III in long-term response to an alternate-day prednisone regimen.
    Braun MC, West CD, Strife CF.
    Am J Kidney Dis; 1999 Dec 17; 34(6):1022-32. PubMed ID: 10585311
    [Abstract] [Full Text] [Related]

  • 19. [Complement and nephritic activity in membranoproliferative glomerulonephritis].
    Lévy M, Sich M, Habib R.
    Arch Fr Pediatr; 1979 Nov 17; 36(9 Suppl):LXIV-LXXIV. PubMed ID: 539879
    [Abstract] [Full Text] [Related]

  • 20. The Association of Class I and II Human Leukocyte Antigen Serotypes With End-Stage Kidney Disease Due to Membranoproliferative Glomerulonephritis and Dense Deposit Disease.
    Afolabi H, Zhang BM, O'Shaughnessy M, Chertow GM, Lafayette R, Charu V.
    Am J Kidney Dis; 2024 Jan 17; 83(1):79-89. PubMed ID: 37739026
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.